Advertisement

Intrathecal baclofen therapy for treatment of spasticity in infants and small children under 6 years of age

  • Christian HagemannEmail author
  • Ilka Schmitt
  • Grischa Lischetzki
  • Philip Kunkel
Original Article

Abstract

Purpose

The aim of this study is to prove the efficacy and safety of intrathecal baclofen therapy in infants and children below 6 years of age by retrospective analysis of our pediatric cohort of 135 primary pump implantations.

Methods

Between 2007 and 2018, 17 patients with pump implantations were below 6 years of age. Data were acquired retrospectively with a follow-up of 12 months to 11 years regarding complications.

Results

The youngest infant was 11 months at implantation with a bodyweight of 6, 4 kg, and 63 cm length. Surgical complications were comparable to published literature and mainly involved the catheter (2 catheter dislocations and 1 catheter transection) and one pump infection resulting in 4 revision surgeries in 3 patients. One baclofen-related apnea during titration and an overdose after refill were treated conservatively. Using a subfascial implantation technique, we observed neither skin ulceration nor pump infection since 2007. In a growing child, catheter slides are common and related to growth, scoliosis, spine surgery, and surgical failure.

Conclusion

Intrathecal baclofen therapy in infants and small children is as safe and effective as published for older pediatric patients; therefore, intrathecal baclofen can be considered in all infants as long as an 8-cm incision fits into the triangle of the anterior superior iliac spine, costal margin of the 10th rib, and navel. We suggest the utilization of subfascial surgical technique for implantation pump and catheter. Titration of intrathecal baclofen should be performed slowly to avoid bradycardia in infants. This is a retrospective study (level of evidence 4).

Keywords

Intrathecal baclofen therapy Baclofen pump implantation Infants Spasticity Cerebral palsy Dystonia Children Pediatrics 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Woolf SM, Baum CR (2017) Baclofen pumps: uses and complications. Pediatr Emerg Care 33(4):271–275CrossRefGoogle Scholar
  2. 2.
    Abe T, Taniguchi W, Nishio N, Nakatsuka T, Yoshida M, Yamada H (2019) Molecular mechanisms of the antispasticity effects of baclofen on spinal ventral horn neurons. Neuroreport 30(1):19–25.  https://doi.org/10.1097/WNR.0000000000001155 CrossRefGoogle Scholar
  3. 3.
    Flack SH, Bernards CM (2010) Cerebrospinal fluid and spinal cord distribution of hyperbaric bupivacaine and baclofen during slow intrathecal infusion in pigs. Anesthesiology 112(1):165–173CrossRefGoogle Scholar
  4. 4.
    Albright AL, Cervi A, Singletary J (1991) Intrathecal baclofen therapy for spasticity in cerebral plasy. JAMA 265:1418–1422CrossRefGoogle Scholar
  5. 5.
    Dickey MP, Rice M, Kinnett DG, Lambert R, Donauer S, Gerber MA, Staat MA (2013) Infectious complications of intrathecal baclofen pump devices in a pediatric population. Pediatr Infect Dis J 32(7):715–722.  https://doi.org/10.1097/INF.0b013e318287f02a CrossRefGoogle Scholar
  6. 6.
    Spader HS, Bollo RJ, Bowers CA, Riva-Cambrin J (2016) Risk factors for baclofen pump infection in children: a multivariate analysis. J Neurosurg Pediatr 17(6):756–762.  https://doi.org/10.3171/2015.11.PEDS15421 CrossRefGoogle Scholar
  7. 7.
    Stewart K, Hutana G, Kentish M (2017) Intrathecal baclofen therapy in paediatrics: a study protocol for an Australian multicentre, 10-year prospective audit. BMJ Open 7(6):e015863.  https://doi.org/10.1136/bmjopen-2017-015863 CrossRefGoogle Scholar
  8. 8.
    Skalsky AJ, Fournier CM (2015) Intrathecal baclofen bolus dosing and catheter tip placement in pediatric tone management. Phys Med Rehabil Clin N Am 26(1):89–93.  https://doi.org/10.1016/j.pmr.2014.09.011 CrossRefGoogle Scholar
  9. 9.
    Ammar A, Ughratdar I, Sivakumar G, Vloeberghs MH (2012) Intrathecal baclofen therapy--how we do it. J Neurosurg Pediatr 10(5):439–444CrossRefGoogle Scholar
  10. 10.
    Motta F, Antonello CE (2014) Analysis of complications in 430 consecutive pediatric patients treated with intrathecal baclofen therapy: 14-year experience. J Neurosurg Pediatr 13(3):301–306.  https://doi.org/10.3171/2013.11 CrossRefGoogle Scholar
  11. 11.
    Berman CM, Eppinger MA, Mazzola CA (2015) Understanding the reasons for delayed referral for intrathecal baclofen therapy in pediatric patients with severe spasticity. Childs Nerv Syst 31(3):405–413CrossRefGoogle Scholar
  12. 12.
    Buizer AI, Martens BHM, Grandbois van Ravenhorst C, Schoonmade LJ, Becher JG, Vermeulen RJ (2019) Effect of continuous intrathecal baclofen therapy in children: a systematic review. Dev Med Child Neurol 61(2):128–134.  https://doi.org/10.1111/dmcn.14005 CrossRefGoogle Scholar
  13. 13.
    Kopell BH, Sala D, Doyle WK, Feldman DS, Wisoff JH, Weiner HL (2001) Subfascial implantation of intrathecal baclofen pumps in children: technical note. Neurosurgery. 49(3):753–756 discussion 756-7Google Scholar
  14. 14.
    Chan DY, Chan SS, Chan EK, Ng AY, Ying AC, Li AC, Chiu CC, Cheung N, Mak WK, Sun DT, Zhu CX, Poon WS (2018) Blessing or burden? Long-term maintenance, complications and clinical outcome of intrathecal baclofen pumps. Surg Pract 22(3):105–110.  https://doi.org/10.1111/1744-1633.12308 CrossRefGoogle Scholar
  15. 15.
    Saulino M, Anderson DJ, Doble J, Farid R, Gul F, Konrad P, Boster AL (2016) Best practices for intrathecal baclofen therapy: troubleshooting. Neuromodulation 19(6):632–641.  https://doi.org/10.1111/ner.12467 CrossRefGoogle Scholar
  16. 16.
    Fjelstad AB, Hommelstad J, Sorteberg A (2009) Infections related to intrathecal baclofen therapy in children and adults: frequency and risk factors. J Neurosurg Pediatr 4(5):487–493.  https://doi.org/10.3171/2009.6.PEDS0921 CrossRefGoogle Scholar
  17. 17.
    Ghobrial GM, Thakkar V, Singhal S, Oppenlander ME, Maulucci CM, Harrop JS, Jallo J, Prasad S, Saulino M, Sharan AD (2014) Efficacy of intraoperative vancomycin powder use in intrathecal baclofen pump implantation procedures: single institutional series in a high risk population. J Clin Neurosci 21(10):1786–1789.  https://doi.org/10.1016/j.jocn.2014.04.007 CrossRefGoogle Scholar
  18. 18.
    Gilmartin R, Bruce D, Storrs BB, Abbott R, Krach L, Ward J, Bloom K, Brooks WH, Johnson DL, Madsen JR, McLaughlin JF, Nadell J (2000) Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J Child Neurol 15(2):71–77CrossRefGoogle Scholar
  19. 19.
    Pucks-Faes E, Hitzenberger G, Matzak H, Fava E, Verrienti G, Laimer I, Fritz J, Saltuari L (2018) Eleven years’ experience with Intrathecal Baclofen - complications, risk factors. Brain Behav 8(5):e00965.  https://doi.org/10.1002/brb3.965 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Pediatric NeurosurgeryAltona Children’s HospitalHamburgGermany
  2. 2.Department of Pediatric NeurologyAltona Children’s HospitalHamburgGermany

Personalised recommendations